Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q3 2024 · 10-Q
Revenue$15.02M$15.02M−45.5% vs Q3 2023 Net Income-$2.51M-$2.51MN/M vs Q3 2023 EPS Diluted-$9.32-$9.32N/M vs Q3 2023 Gross Profit$4,232,000−24.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flowderived-$417,000N/M Free Cash Flowderived-$554,000N/M Margins · derivedGross margin28.2%+7.8 pt vs Q3 2023
Operating margin-15.8%−18.3 pt vs Q3 2023
Net margin-16.7%−18.6 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 13, 2024 · 44 d after period end